Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer.
Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer.
复制标题
DOI:
10.1016/j.ygyno.2018.02.012
复制
发表时间:
2018-05
影响因子:
4.7
通讯作者:
Roman LD
中科院分区:
文献类型:
--
作者:
Matsuo K;Yabuno A;Hom MS;Shida M;Kakuda M;Adachi S;Mandelbaum RS;Ueda Y;Hasegawa K;Enomoto T;Mikami M;Roman LD
To examine survival of women with stage I–II endometrioid endometrial cancer whose peritoneal cytology showed malignant or atypical cells (abnormal peritoneal cytology). This is a multi-center retrospective study examining 1668 women with stage I–II endometrioid endometrial cancer who underwent primary hysterectomy with available peritoneal cytology results between 2000 and 2015. Abnormal peritoneal cytology was correlated to clinico-pathological characteristics and oncological outcome. Malignant and atypical cells were seen in 125 (7.5%) and 58 (3.5%) cases, respectively. On multivariate analysis, non-obesity, non-diabetes mellitus, cigarette use, and lympho-vascular space invasion were independently associated with abnormal peritoneal cytology (all, P < 0.05). Abnormal peritoneal cytology was independently associated with decreased disease-free survival (hazard ratio 3.07, P < 0.001) and cause-specific survival (hazard ratio 3.42, P = 0.008) on multivariate analysis. Abnormal peritoneal cytology was significantly associated with increased risks of distant-recurrence (5-year rates: 8.8% versus 3.6%, P = 0.001) but not local-recurrence (5.2% versus 3.0%, P = 0.32) compared to negative cytology. Among women with stage I disease, abnormal peritoneal cytology was significantly associated with an increased risk of distant-recurrence in the low risk group (5-year rates: 5.5% versus 1.0%, P < 0.001) but not in the high-intermediate risk group (13.3% versus 10.8% P = 0.60). Among 183 women who had abnormal peritoneal cytology, postoperative chemotherapy significantly reduced the rate of peritoneal recurrence (5-year rates: 1.3% versus 9.2%, P = 0.039) whereas postoperative radiotherapy did not (7.1% versus 5.5%, P = 0.63). Our study suggests that abnormal peritoneal cytology may be a prognostic factor for decreased survival in women with stage I–II endometrioid endometrial cancer, particularly for low-risk group.
登录
查看更多内容
DOI:
10.1097/igc.0000000000001181
发表时间:
2018-03
期刊:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
影响因子:
--
作者:
Machida H;Hom MS;Adams CL;Eckhardt SE;Garcia-Sayre J;Mikami M;Matsuo K
通讯作者:
Matsuo K
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
8.8
作者:
Kasamatsu, T;Onda, T;Matsuno, Y
通讯作者:
Matsuno, Y
影响因子:
7.5
作者:
Fadare, O;Mariappan, MR;Rimm, DL
通讯作者:
Rimm, DL
DOI:
10.1016/s0360-3016(96)00619-0
发表时间:
1997-03-01
影响因子:
7
作者:
Gaspar, L;Scott, C;Byhardt, R
通讯作者:
Byhardt, R